Abstract
Chlamydia trachomatis (CT) and Neisseria gonorrhea (GC) are common sexually transmitted infections in the United States with significant public health implications. Emerging trends of seasonal GC and the most current recommendations for screening, diagnosing, and treatment of CT and GC infections are presented. Multi-drug-resistant GC is an urgent public health threat: zoliflodacin, a new antibiotic under development, and the most recent provider guidelines by the Centers for Disease Control and Prevention are reviewed. Health care providers, including nurse practitioners, can improve health outcomes related to these STIs by staying abreast of the most recent treatment recommendations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
